Showing results (1101-1110 of 1,757) with videos related to
Sort By:
Pageof 176
Advanced Synthesis & Catalysis|September 19, 2017
A Methylidene Group in the Phosphonic Acid Analogue of Phenylalanine Reverses the Enantiopreference of Binding to Phenylalanine Ammonia-LyasesZsófia Bata, Renzhe Qian, Alexander Roller, et al.Nature Communications|May 10, 2016
Spontaneous helix formation in non-chiral bent-core liquid crystals with fast linear electro-optic effectSithara P Sreenilayam, Yuri P Panarin, Jagdish K Vij, et al.Farmakologiia I Toksikologiia|May 1, 1990
[The relationship between the chemical structure and anti-arrhythmia action of a number of omega-aminoacyl-3-carbalcoxyaminodibenzazepines]A N Gritsenko, V V Lyskovtsev, Z P Senova, et al.Ebiomedicine|August 29, 2020
Effect of antenatal magnesium sulphate on MRI biomarkers of white matter development at term equivalent age: The magnum studyTanya Poppe, Benjamin Thompson, James P Boardman, et al.Heart (British Cardiac Society)|August 3, 2023
Widening ethnic inequities in heart failure incidence in New ZealandDaniel Zl Chan, Corina Grey, Rob N Doughty, et al.The New Zealand Medical Journal|September 30, 2020
Inequity in one-year mortality after first myocardial infarction in Māori and Pacific patients: how much is associated with differences in modifiable clinical risk factors? (ANZACS-QI 49)Janine Mazengarb, Corina Grey, Mildred Lee, et al.Haematologica|September 13, 2005
Novel cryptic chromosomal rearrangements in childhood acute lymphoblastic leukemia detected by multiple color fluorescent in situ hybridizationBruce Poppe, Barbara Cauwelier, Heidi Van Limbergen, et al.Acta Clinica Belgica|October 19, 2000
Repetitive analyses of P-glycoprotein in chronic myeloid leukaemiaB De Moerloose, A Muylaert, F Gemmel, et al.Age and Ageing|January 25, 2022
Cardiovascular disease preventive medication dispensing for almost every New Zealander 65 years and over: a preventive treatment paradox?Sue Wells, Yeunhyang Choi, Rod Jackson, et al.Cancer Research|February 1, 1992
In vivo targeting of OV-TL 3 immunoliposomes to ascitic ovarian carcinoma cells (OVCAR-3) in athymic nude miceU K Nässander, P A Steerenberg, H Poppe, et al.Pageof 176